The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.

The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts.

The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, 2025, follows an inspection conducted from June 12 to July 9, 2024, and outlines multiple manufacturing violations for pharmaceuticals.

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. | The FDA has slapped a warning letter on Sanofi’s Genzyme facility in Framingham,

Elshoma McCoy, 49, of 176 Waverly St., Framingham, is charged with illegal possession of a firearm; illegal possession of a large capacity feeding device; improper storage of a firearm; trafficking in cocaine; and possession of cocaine with the intent to distribute.

When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.

A fast-casual restaurant that serves Korean and Mexican food has received approval to open on Route 9 in Framingham.

The owners of 3 Idlewile Lane in Weston admired a home they saw in Architectural Digest, so they purchased over eight acres of land in an exclusive spot in south Weston and replicated the English Arts and Crafts-style dream house on the site.

Framingham-based retail parent TJX Cos. has purchased two office parcels on Framingham’s Speen Street for $24.3 million.

Thomas Method said he entered the Capitol building but left within 10 minutes because he didn't know it was going to turn violent.

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, end-stage kidney disease and cardiovascular disease-caused death for patients with type 2 diabetes and chronic kidney disease.

There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as well as a lack of good old-fashioned common sense.